Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling

Clinical trial NCT06748950 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06748950
Sponsor: Stanford University
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Schizophrenia Schizophrenia and Related Disorders Bipolar Disorder Bipolar and Related Disorders Major Depressive Disorder Major Depression Severe Ketogenic Dieting Ketosis Metabolic Disease Metabolic Syndrome

Start date: 2025-07-01
Primary completion: 2028-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.